CME [CME] vs S&P Global [SPGI] Detailed Stock Comparison

CME Group Inc.

NASDAQ
Loading...

S&P Global Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: CME Group Inc. wins in 10 metrics, S&P Global Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric CME Group Inc. S&P Global Inc. Better
P/E Ratio (TTM) 24.34 29.75 CME Group Inc.
Price-to-Book Ratio 3.57 4.19 CME Group Inc.
Debt-to-Equity Ratio 12.86 37.91 CME Group Inc.
PEG Ratio 1.03 0.93 S&P Global Inc.
EV/EBITDA 21.55 19.29 S&P Global Inc.
Profit Margin (TTM) 63.31% 29.15% CME Group Inc.
Operating Margin (TTM) 69.66% 38.25% CME Group Inc.
EBITDA Margin (TTM) 69.66% 38.25% CME Group Inc.
Return on Equity 15.92% 13.09% CME Group Inc.
Return on Assets (TTM) 1.55% 6.66% S&P Global Inc.
Free Cash Flow (TTM) $4.19B $5.46B S&P Global Inc.
Dividend Yield 4.11% 0.88% CME Group Inc.
1-Year Return 0.01% -16.47% CME Group Inc.
Price-to-Sales Ratio (TTM) 15.36 8.51 S&P Global Inc.
Enterprise Value $103.28B $147.44B S&P Global Inc.
EV/Revenue Ratio 15.31 9.61 S&P Global Inc.
Gross Profit Margin (TTM) N/A 70.12% N/A
Revenue per Share (TTM) $19 $50 S&P Global Inc.
Earnings per Share (Diluted) $11.73 $14.68 S&P Global Inc.
Beta (Stock Volatility) 0.30 1.20 CME Group Inc.
Short % of Float 1.44% 1.02% S&P Global Inc.

CME Group Inc. vs S&P Global Inc. Stock Performance Analysis

Loading Price Chart...

CME
SPGI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%
S&P Global Inc.1.23%1.67%5.19%-0.59%-15.12%-17.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%
S&P Global Inc.-16.47%6.00%7.22%292.46%957.59%699.29%

Performance & Financial Health Analysis: CME Group Inc. vs S&P Global Inc.

MetricCMESPGI
Market Information
Market Cap i$103.42B$130.51B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,489,6541,721,110
90 Day Avg. Volume i2,270,2211,870,297
Last Close$266.08$424.07
52 Week Range$244.56 - $329.16$381.61 - $579.05
% from 52W High-19.16%-26.76%
All-Time High$329.16 (Mar 03, 2026)$579.05 (Aug 14, 2025)
% from All-Time High-19.16%-26.76%
Growth Metrics
Quarterly Revenue Growth0.15%0.09%
Quarterly Earnings Growth0.21%0.29%
Financial Health
Profit Margin (TTM) i0.63%0.29%
Operating Margin (TTM) i0.70%0.38%
Return on Equity (TTM) i0.16%0.13%
Debt to Equity (MRQ) i12.8637.91
Cash & Liquidity
Book Value per Share (MRQ)$80.03$104.17
Cash per Share (MRQ)$7.56$6.03
Operating Cash Flow (TTM) i$4.54B$5.65B
Levered Free Cash Flow (TTM) i$4.11B$4.88B
Dividends
Last 12-Month Dividend Yield i4.11%0.88%
Last 12-Month Dividend i$12.45$3.85

Valuation & Enterprise Metrics Analysis: CME Group Inc. vs S&P Global Inc.

MetricCME (Apr 26, 2026)SPGI (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i24.3429.75
Forward P/E i22.1419.78
PEG Ratio i1.030.93
Price to Sales (TTM) i15.368.51
Price to Book (MRQ) i3.574.19
Market Capitalization
Market Capitalization i$103.42B$130.51B
Enterprise Value i$103.28B$147.44B
Enterprise Value Metrics
Enterprise to Revenue i15.319.61
Enterprise to EBITDA i21.5519.29
Risk & Other Metrics
Beta i0.301.20
Book Value per Share (MRQ) i$80.03$104.17

Financial Statements Comparison: CME Group Inc. vs S&P Global Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCME (2025)SPGI (2025)
Revenue/Sales i6.52B15.34B
Cost of Goods Sold i907.00M4.56B
COGS % of Revenue i13.9%29.8%
Gross Profit i5.61B10.77B
Gross Margin i86.1%70.2%
Research & Development iN/AN/A
Operating Income (EBIT) i4.23B6.18B
Operating Margin i64.9%40.3%
EBITDA i98.30M7.41B
EBITDA Margin i1.5%48.3%
Pre-Tax Income i5.33B6.23B
Pre-Tax Income % of Revenue i81.7%40.6%
Income Tax i1.26B1.41B
Income Tax % of Revenue i19.3%9.2%
Net Income (Profit) i4.07B4.82B
Profit Margin i62.5%31.4%

Balance Sheet & Liquidity Metrics

MetricCME (2025)SPGI (2025)
Cash & Equivalents i4.42B1.75B
Total Current Assets i165.36B6.30B
Total Current Assets % of Revenue i2,536.0%41.1%
Total Current Liabilities i160.30B7.64B
Total Current Liabilities % of Revenue i2,458.3%49.8%
Long-Term Debt i3.42B12.86B
Long-Term Debt % of Revenue i52.5%83.9%
Total Shareholders Equity i28.73B36.15B
Retained Earnings i6.43B23.67B
Retained Earnings % of Revenue i98.7%154.3%
Property, Plant & Equipment i0857.00M

Cash Flow Statement Comparison

MetricCME (2025)SPGI (2025)
Operating Cash Flow i4.54B5.75B
Operating Cash Flow % of Revenue i69.6%37.5%
Capital Expenditures i-83.50MN/A
Free Cash Flow i4.19B5.46B
FCF Margin i64.3%35.6%
Debt Repayment i-750.00M-4.00M
Common Stock Repurchase i-266.10M-5.00B

Short Interest & Institutional Ownership Analysis

MetricCMESPGI
Shares Short i4.70M3.03M
Short Ratio i2.281.53
Short % of Float i1.44%1.02%
Shares Outstanding i362.80M298.80M
Float Shares i357.72M298.09M
% Held by Insiders i0.48%0.33%
% Held by Institutions i91.89%89.24%
% Held by Public i7.63%10.43%

Dividend Analysis & Yield Comparison: CME Group Inc. vs S&P Global Inc.

MetricCMESPGI
Last 12-Month Dividend i$12.45$3.85
Last 12-Month Dividend Yield i4.11%0.88%
3-Year Avg Annual Dividend i$10.83$3.72
3-Year Avg Dividend Yield i0.92%0.20%
3-Year Total Dividends i$32.50$11.15
Ex-Dividend DateMar 10, 2026Feb 25, 2026